FOAMIX PHARMACEUTICALS LTD's ticker is FOMX and the CUSIP is M46135105. A total of 66 filers reported holding FOAMIX PHARMACEUTICALS LTD in Q1 2016. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2017 | $1,000 | 0.0% | 200 | 0.0% | 0.00% | – |
Q2 2017 | $1,000 | 0.0% | 200 | 0.0% | 0.00% | – |
Q1 2017 | $1,000 | -50.0% | 200 | 0.0% | 0.00% | – |
Q4 2016 | $2,000 | 0.0% | 200 | 0.0% | 0.00% | – |
Q3 2016 | $2,000 | +100.0% | 200 | 0.0% | 0.00% | – |
Q2 2016 | $1,000 | -50.0% | 200 | 0.0% | 0.00% | – |
Q4 2015 | $2,000 | – | 200 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |
NATIONS FINANCIAL GROUP INC, /IA/ /ADV | 20,150 | $0 | 0.00% |
Advisory Services Network, LLC | 2,233 | $0 | 0.00% |
Fernwood Investment Management, LLC | 34,000 | $0 | 0.00% |